Factor VIIa and anti-inhibitor complexes are used in the treatment of patients whose immune systems have developed antibodies, called inhibitors, to the coagulation factors normally used to treat hemophilia A and B. Factor VIIa is also indicated for the treatment of other serious, sometimes life-threatening bleeding conditions. Factor products are supplied in vials sizes of varying iu (international units) which may change with each new lot of product manufactured. |
|
